drugset / Trial / NCT07422233

Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults

NCT07422233

Phase 4 Completed 137 enrolled Nasim Tabrizi
NaSingle-groupOpen-labelTreatment

Summary

This prospective interventional study was conducted between 2023 and 2025 at the Department of Neurology of Bouali Sina Hospital. Consecutive elderly patients presenting with epilepsy were screened for eligibility. The diagnosis of epilepsy was confirmed by the treating neurologist. The patients underwent treatment with levetiracetam. Primary and secondary outcomes were investigated as was explained before.

Timeline

Start
2023-09-13
Primary completion
2025-12-31
Completion
2026-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified Oral

Indications